908 Devices Inc (MASS) News

Form 8-K - Current report

Form 8-K - Current report

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

WALTHAM, Mass. and BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq: RGEN), a life...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

Full year 2024 reported revenue growth of at least 15% compared to 2023 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters

Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ MAVEN for...

Form 4 - Statement of changes in beneficial ownership of securities

908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

Revenue increases 17% compared to prior year, driven by recently acquired handheld products 908 Devices Inc. (Nasdaq: MASS), a pioneer of...

908 Devices to Participate in Upcoming Investor Conferences

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors